Gene · 3702
Papers2,789
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,789
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring the significance of tumor volume in endometrial cancer: Clinical pathological features, prognosis, and adjuvant therapies. | Medicine (Baltimore) | 2023 | 38115321 | PubTator, text mining | PubMed |
| Combined Immunodeficiency Caused by a Novel Nonsense Mutation in LCK. | J Clin Immunol | 2023 | 38112969 | PubTator, text mining | PubMed |
| A Novel Biallelic LCK Variant Resulting in Profound T-Cell Immune Deficiency and Review of the Literature. | J Clin Immunol | 2023 | 38100037 | PubTator, text mining | PubMed |
| Caprin-1 influences autophagy-induced tumor growth and immune modulation in pancreatic cancer. | J Transl Med | 2023 | 38082307 | PubTator, text mining | PubMed |
| Conformational Selectivity of ITK Inhibitors: Insights from Molecular Dynamics Simulations. | J Chem Inf Model | 2023 | 38069816 | PubTator, text mining | PubMed |
| Differential Diagnosis: Hepatic Complications in Inborn Errors of Immunity. | J Clin Med | 2023 | 38068532 | PubTator, text mining | PubMed |
Severe infections requiring intensive care unit admission in patients receiving ibrutinib for hematological malignancies: a groupe de recherche respiratoire en réanimation onco-hématologique (GRRR-OH) study. | Ann Intensive Care | 2023 | 38055081 | PubTator, text mining | PubMed |
| Multilevel omics for the discovery of biomarkers in pediatric sepsis. | Pediatr Investig | 2023 | 38050541 | PubTator, text mining | PubMed |
| Predictive model for early death risk in pediatric hemophagocytic lymphohistiocytosis patients based on machine learning. | Heliyon | 2023 | 38045172 | PubTator, text mining | PubMed |
| Zanubrutinib in Mantle Cell Lymphoma Management: A Comprehensive Review. | Blood Lymphat Cancer | 2023 | 38034984 | PubTator, text mining | PubMed |
| Breast cancer therapies reduce risk of Alzheimer's disease and promote estrogenic pathways and action in brain. | iScience | 2023 | 38026173 | PubTator, text mining | PubMed |
| Tumor cell cytoplasmic metallothionein expression associates with differential tumor immunogenicity and prognostic outcome in high-grade serous ovarian carcinoma. | Front Oncol | 2023 | 38023247 | PubTator, text mining | PubMed |
| The implication of next-generation sequencing in the diagnosis and clinical management of non-Hodgkin lymphomas. | Front Oncol | 2023 | 38023160 | PubTator, text mining | PubMed |
| T-helper cells flexibility: the possibility of reprogramming T cells fate. | Front Immunol | 2023 | 38022605 | PubTator, text mining | PubMed |
| Inhibition of T-cell activity in alopecia areata: recent developments and new directions. | Front Immunol | 2023 | 38022501 | PubTator, text mining | PubMed |
| Cancer and cardiotoxicity in the transgender population. | Arch Cardiol Mex | 2023 | 37992701 | PubTator, text mining | PubMed |
| Targeting kinase ITK treats autoimmune arthritis via orchestrating T cell differentiation and function. | Biomed Pharmacother | 2023 | 37992572 | PubTator, text mining | PubMed |
| Preclinical evidence for the effective use of TL-895, a highly selective and potent second-generation BTK inhibitor, for the treatment of B-cell malignancies. | Sci Rep | 2023 | 37989777 | PubTator, text mining | PubMed |
| Phospholipase C-γ as a Potential Therapeutic Target for Graves' Orbitopathy. | Endocrinol Metab (Seoul) | 2023 | 37989267 | PubTator, text mining | PubMed |
| Leveraging diverse cell-death patterns to predict the prognosis, immunotherapy and drug sensitivity of clear cell renal cell carcinoma. | Sci Rep | 2023 | 37985807 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3702/papers?page=9